Tech Company Financing Transactions
Rubius Therapeutics Funding Round
Rubius Therapeutics, based in Cambridge, raised $100 million from private investors.
Transaction Overview
Company Name
Announced On
3/1/2018
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The addition of this funding further strengthens our foundation and enables us to accelerate the development of our first wave of RCT products that are targeting treatment of enzyme deficiencies, cancer and autoimmune disease.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
325 Vassar St. 1A
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Rubius is developing a new class of drugs, Red-Cell Therapeutics, for the treatment of a wide array of diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Pablo Cagnoni
Chief Financial Officer
Andrew Oh
Chief Medical Officer
Chris Carpenter
President
Torben Nissen
VP - Bus. Development
Nathan Dowden
VP - Finance
Joanne Protano
VP - Manufacturing
Spencer Fisk
VP - Manufacturing
Robert Konopacz
VP - R & D
Thomas Wickham
Browse more venture capital transactions:
Prev: 3/1/2018: Automox venture capital transaction
Next: 3/1/2018: Viela Bio venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs